Archive: 18/07/2017
Nerlynx approved to help prevent breast cancer's return
(HealthDay)—Nerlynx (neratinib) has been approved by the U.S. Food and Drug Administration to help prevent HER2-positive breast cancer from returning.
Jul 18, 2017
(HealthDay)—Nerlynx (neratinib) has been approved by the U.S. Food and Drug Administration to help prevent HER2-positive breast cancer from returning.
Jul 18, 2017